As jurisdictions across the US begin implementing and enforcing disparate legislation mandating drug take-back programs, the burden of funding and execution has fallen upon pharmaceutical manufacturers.
The regulatory, operational, and financial challenges that accompany this legislation are exacerbated as the industry navigates political and economic uncertainty, all while trying to maintain a primary focus on patient outcomes and public health.
Join the Inmar Intelligence team as we unpack critical drug take-back considerations for the pharma community. Attendees of this webinar will be equipped with answers to key questions such as:
- Where and when am I expected to be compliant?
- What does compliance look like?
- How do I keep my finger on the pulse of legislative developments?
- What will the regulatory landscape look like in the future?